| Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer (NCT02551432) | Seoul National University Hospital | 2015-09-01 |
| Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) (NCT02499770) | G1 Therapeutics, Inc. | 2015-06-26 |
| Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers (NCT02349412) | Alliance for Clinical Trials in Oncology | 2015-06-25 |
| SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma (NCT02500914) | Stemcentrx | 2015-06-01 |
| A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer (NCT02391480) | AbbVie | 2015-04-14 |
| Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors (NCT02367352) | Millennium Pharmaceuticals, Inc. | 2015-03-19 |
| Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer (NCT02348450) | Guangdong Association of Clinical Trials | 2015-02-01 |
| Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer (NCT02337712) | Sun Yat-sen University | 2015-01-01 |
| FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer (NCT02995902) | Rigshospitalet, Denmark | 2014-12-11 |
| Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) (NCT02331251) | Western Regional Medical Center | 2014-12-01 |
| BMS-986012 in Relapsed/Refractory SCLC (NCT02247349) | Bristol-Myers Squibb | 2014-11-14 |
| Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies (NCT02223052) | Celgene | 2014-10-27 |
| Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer (NCT02289690) | AbbVie | 2014-10-13 |
| A Phase I/II Study of Ganetespib in Combination With Doxorubicin (NCT02261805) | Georgetown University | 2014-10-01 |
| Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment (NCT02297087) | Western Regional Medical Center | 2014-10-01 |
| Molecular Signatures of Relapse in Tissue Samples From Patients With Small Cell Lung Cancer Who Are Receiving Cisplatin and Etoposide (NCT02250404) | University of Southern California | 2014-08-22 |
| DC Vaccine Combined With CIK Cells in Patients With SCLC (NCT02688673) | Affiliated Hospital to Academy of Military Medical Sciences | 2014-08-01 |
| Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLC (NCT02058056) | Swiss Cancer Institute | 2014-07-11 |
| A Study to Evaluate the Good and Bad Effects of BIBF1120 in Small Cell Lung Cancer Patients Who Have Previously Benefited From First-line Platinum-based Chemotherapy (NCT02152059) | AHS Cancer Control Alberta | 2014-07-01 |
| Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment (NCT02171325) | Guangdong Association of Clinical Trials | 2014-06-01 |
| Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors (NCT02146170) | National Cancer Institute (NCI) | 2014-05-28 |
| Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC) (NCT02038647) | Millennium Pharmaceuticals, Inc. | 2014-05-12 |
| Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer (NCT01575782) | Maastricht Radiation Oncology | 2014-05-01 |
| A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations (NCT02109016) | Clovis Oncology, Inc. | 2014-04-01 |
| Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC (NCT02200081) | Mologen AG | 2014-03-01 |
| The Effect of Caphosol® on the Development of Esophagitis in (N)SCLC Patients Treated With Concurrent Chemo/Radiotherapy (NCT01809756) | Amphia Hospital | 2014-02-25 |
| Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients (NCT02039518) | Fudan University | 2013-12-01 |
| Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients (NCT00969306) | Maastricht Radiation Oncology | 2013-09-01 |
| Value of Physical Capacity Tests in Lung Cancer (NCT01943578) | Rigshospitalet, Denmark | 2013-09-01 |
| The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer (NCT02262897) | Tongji University | 2013-09-01 |
| Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors (NCT01831089) | PharmaMar | 2013-09-01 |
| SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013 (NCT02738346) | University Hospital, Angers | 2013-07-01 |
| Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer (NCT01880528) | Mayo Clinic | 2013-05-31 |
| Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011) (NCT01840579) | Merck Sharp & Dohme LLC | 2013-04-26 |
| Hippocampus Avoidance PCI vs PCI (NCT01780675) | The Netherlands Cancer Institute | 2013-04-01 |
| Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer (NCT01797159) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-03-11 |
| Hair-sparing Whole Brain Radiotherapy (NCT01421316) | University Hospital, Ghent | 2013-01-01 |
| Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer (NCT01631552) | Gilead Sciences | 2012-12-17 |
| Vinorelbine and Ifosfamide as Third-line Treatment for Refractory Small Cell Lung Cancer (NCT01752517) | Peking Union Medical College Hospital | 2012-12-01 |
| A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer (NCT01872416) | The First Affiliated Hospital of Guangzhou Medical University | 2012-10-01 |
| Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung Cancer (NCT01592422) | People's Hospital of Guangxi Zhuang Autonomous Region | 2012-07-01 |
| MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases (NCT01640847) | Imunon | 2012-07-01 |
| Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer (NCT01500720) | Sanofi | 2012-03-01 |
| Exercise in Advanced Stage Lung Cancer Patients (NCT01881906) | Rigshospitalet, Denmark | 2012-02-01 |
| Clinical Randomized Study of Concurrent Chemo-radiotherapy vs Radiotherapy Alone to Local-advanced Small Cell Lung Cancer (SCLC) (NCT01745445) | Tianjin Medical University Cancer Institute and Hospital | 2012-01-01 |
| Effect of Hyponatremia in Small Cell Lung Cancer (NCT04451460) | Ankara City Hospital Bilkent | 2012-01-01 |
| Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC) (NCT01487499) | University of Florida | 2011-12-01 |
| BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer (NCT01441297) | Ji-youn Han | 2011-12-01 |
| Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer (NCT01426841) | AHS Cancer Control Alberta | 2011-08-01 |
| A Phase Ib/II Trial of Belotecan and Ifosfamide in Patients With Extensive Disease of Small Cell Lung Cancer (NCT01784107) | Gachon University Gil Medical Center | 2011-07-01 |
| Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer (NCT01417806) | South Florida Veterans Affairs Foundation for Research and Education | 2011-07-01 |
| TF2- Small Cell Lung Cancer Radio Immunotherapy (NCT01221675) | Centre René Gauducheau | 2011-06-01 |
| Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies (NCT01401907) | Massachusetts General Hospital | 2011-05-01 |
| A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer (NCT01591512) | Fujirebio Diagnostics, Inc. | 2011-05-01 |
| HYPAZ: Hypertension Induced by Pazopanib (NCT01392352) | Cambridge University Hospitals NHS Foundation Trust | 2011-04-01 |
| A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors (NCT00455052) | Mersana Therapeutics | 2011-03-01 |
| Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer (NCT01266018) | Ludwig Institute for Cancer Research | 2011-01-01 |
| Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy (NCT01159327) | National Cancer Center, Korea | 2010-12-01 |
| A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer (NCT01237678) | ImmunoGen, Inc. | 2010-11-01 |
| Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies (NCT01242072) | Alaunos Therapeutics | 2010-11-01 |
| A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer (NCT01497873) | Chong Kun Dang Pharmaceutical | 2010-09-01 |
| Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation (NCT01182155) | Stanford University | 2010-08-01 |
| Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer (NCT01173523) | David M. Jackman, MD | 2010-07-28 |
| Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC) (NCT01173458) | University of Kansas Medical Center | 2010-07-01 |
| A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients (NCT01429766) | Tata Memorial Hospital | 2010-06-01 |
| Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies (NCT01045421) | Millennium Pharmaceuticals, Inc. | 2010-02-01 |
| Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer (NCT01069653) | Shiga University | 2010-02-01 |
| Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer (NCT01079481) | Samsung Medical Center | 2009-12-01 |
| A Study for Participants With Small-Cell Lung Cancer (NCT01025284) | Eli Lilly and Company | 2009-12-01 |
| An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors (NCT01040312) | Daiichi Sankyo Co., Ltd. | 2009-10-15 |
| Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies (NCT00921739) | Duke University | 2009-09-11 |
| Bevacizumab in Extensive Small Cell Lung Cancer (NCT00930891) | Intergroupe Francophone de Cancerologie Thoracique | 2009-09-01 |
| Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer (NCT00958022) | Ahmad Tarhini | 2009-09-01 |
| Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment (NCT02105168) | Gustave Roussy, Cancer Campus, Grand Paris | 2009-07-01 |
| A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer (NCT00951613) | Nippon Kayaku Co., Ltd. | 2009-07-01 |
| Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) (NCT00912392) | Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd | 2009-05-01 |
| Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer (NCT00856830) | University of Alabama at Birmingham | 2009-04-01 |
| Study of Oral Vorinostat in Combination With Topotecan in Patients With Chemosensitive Recurrent SCLC (NCT00697476) | Armando Santoro, MD | 2009-01-01 |
| QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer (NCT00791154) | NantCell, Inc. | 2008-12-02 |
| Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors (NCT00765973) | Spectrum Pharmaceuticals, Inc | 2008-11-10 |
| Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer (NCT00702962) | Milton S. Hershey Medical Center | 2008-09-01 |
| A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) (NCT00916669) | Massachusetts General Hospital | 2008-07-01 |
| Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer (NCT00695292) | SCRI Development Innovations, LLC | 2008-06-01 |
| INNO-206 in Patients With Small Cell Lung Cancer (SCLC) (NCT00472771) | CytRx | 2008-05-01 |
| Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer (NCT00755157) | University Hospital of Crete | 2008-04-01 |
| Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer (NCT00613626) | Hoosier Cancer Research Network | 2008-01-01 |
| Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer (NCT00546130) | University of Toyama | 2007-11-01 |
| To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid (NCT00617409) | H. Lee Moffitt Cancer Center and Research Institute | 2007-10-02 |
| Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer (NCT00475657) | Eli Lilly and Company | 2007-10-01 |
| Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma (NCT00531284) | Amgen | 2007-09-01 |
| AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy (NCT00547651) | Celgene | 2007-09-01 |
| Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC) (NCT00494026) | Eli Lilly and Company | 2007-09-01 |
| STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study (NCT00526396) | National Cancer Institute, Naples | 2007-09-01 |
| Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung Cancer (NCT00686985) | Dr. B. Biesma | 2007-09-01 |
| Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer (NCT00776295) | H. Lee Moffitt Cancer Center and Research Institute | 2007-05-01 |
| Study of Picoplatin Efficacy After Relapse (NCT00465491) | Poniard Pharmaceuticals | 2007-04-01 |
| Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients (NCT00466466) | Novartis Pharmaceuticals | 2007-04-01 |
| A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies (NCT00445198) | AbbVie (prior sponsor, Abbott) | 2007-04-01 |
| A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) (NCT00403403) | Genentech, Inc. | 2007-03-01 |
| Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma (NCT00483509) | AGC Biologics S.p.A. | 2007-02-14 |